Dr. Gonzalez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1250 8th Ave
Suite 515
Fort Worth, TX 76104Phone+1 817-922-9968Fax+1 817-922-9762- Is this information wrong?
Education & Training
- Stanford Health CareFellowship, Transplant Hepatology, 2007 - 2008
- Columbia Mailman School of Public HealthMS, Biostatistics, 2005 - 2007
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2004 - 2007
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
- Geisel School of Medicine at DartmouthClass of 2000
Certifications & Licensure
- CA State Medical License 2007 - Present
- TX State Medical License 2008 - 2025
- NY State Medical License 2002 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Start of enrollment: 2011 Oct 01
- Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 Start of enrollment: 2016 Jul 13
Publications & Presentations
PubMed
- Priority for kidney after liver transplantation: A safety net for all?Stevan A Gonzalez, Sumeet K Asrani> ;Liver Transplantation. 2024 Feb 29
- 1 citationsINFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion.Ethan Weinberg, Suditi Rahematpura, Stevan A Gonzalez, Manhal J Izzy, Douglas A Simonetto, R Todd Frederick, Raymond A Rubin, Jade Ikahihifo-Bender, Maggie Harte, Grac...> ;Contemporary Clinical Trials Communications. 2023 Dec 1
- Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.Stevan A Gonzalez, Viktor V Chirikov, Wei-Jhih Wang, Xingyue Huang, Khurram Jamil, Douglas A Simonetto> ;Clinical and Translational Gastroenterology. 2023 Dec 1
- Join now to see all
Journal Articles
- INFUSE: Rationale and Design of a Multi-Center, Open Label, Collaborative Study to Treat HRS-AKI with Continuous Terlipressin Infusion.Weinberg E, Rahematpura S, Gonzalez SA, Izzy MJ, Simonetto DA, Frederick RT, Rubin RA, Ikahihifo-Bender J, Harte, M, Kim-Lee G, Witkiewicz S, Tobin W, Jamil K, Fricker..., Contemporary Clinical Trials Communications
- Terlipressin versus Midodrine plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.Gonzalez SA, Chirikov VV, Wang WJ, Huang X, Jamil K, Simonetto DA., Clinical and Translational Gastroenterology
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
Press Mentions
- Smartphone App to Assess Stool Form, Rural-Urban Disparities in Cirrhosis Mortality, Lung Infection Risk in Severe Alcoholic Hepatitis in July Issue of AJGJuly 5th, 2022
- COMMENTARY: COVID Collaboration: Working Group Demonstrates Potential for InnovationMarch 19th, 2021
Professional Memberships
- Member
- American Association for the Study of Liver Disease - AASLDMember
- American Society of Transplantation - ASTMember
Other Languages
- Spanish
Hospital Affiliations
- Baylor Scott & White All Saints Medical Center - Fort WorthFort Worth, Texas
- Baylor University Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: